Study on the Treatment of Adolescent Patients With Seasonal Allergic Rhinitis

NCT07678931 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

136

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Allergic Rhinitis (SAR)

Interventions

BIOLOGICAL: Stapokibart
DRUG: Placebo

Sponsor

Chengdu Kangnuoxing Biopharma,Inc.